160 related articles for article (PubMed ID: 29268400)
1. Lymph node involvement according to lung adenocarcinoma subtypes: lymph node involvement is influenced by lung adenocarcinoma subtypes.
Park JK; Kim JJ; Moon SW; Lee KY
J Thorac Dis; 2017 Oct; 9(10):3903-3910. PubMed ID: 29268400
[TBL] [Abstract][Full Text] [Related]
2. Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.
Zhao Y; Wang R; Shen X; Pan Y; Cheng C; Li Y; Shen L; Zhang Y; Li H; Zheng D; Ye T; Zheng S; Sun Y; Chen H
Ann Surg Oncol; 2016 Jun; 23(6):2099-105. PubMed ID: 26842488
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
4. Lymph node involvement influenced by lung adenocarcinoma subtypes in tumor size ≤3 cm disease: A study of 2268 cases.
Yu Y; Jian H; Shen L; Zhu L; Lu S
Eur J Surg Oncol; 2016 Nov; 42(11):1714-1719. PubMed ID: 27017272
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Kitagawa S; Zenke Y; Taki T; Aokage K; Sakai T; Shibata Y; Izumi H; Nosaki K; Umemura S; Matsumoto S; Yoh K; Sakamoto N; Sakashita S; Kojima M; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2024 Feb; 188():107453. PubMed ID: 38160515
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Non-Predominant Micropapillary Pattern in a Large Cohort of Resected Invasive Lung Adenocarcinoma Measuring ≤3 cm.
Zhang H; Huang W; Liu C; Giaccone G; Zhao X; Sun X; Li J; Cheng R; Huang Q; Mo H; Zhang Z; Zhang B; Wang C
Front Oncol; 2021; 11():657506. PubMed ID: 34026636
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinoma.
Suda K; Sato K; Shimizu S; Tomizawa K; Takemoto T; Iwasaki T; Sakaguchi M; Mitsudomi T
Biomed Res Int; 2014; 2014():645681. PubMed ID: 25371901
[TBL] [Abstract][Full Text] [Related]
8. Minor components of micropapillary and solid subtypes in lung invasive adenocarcinoma (≤ 3 cm): PET/CT findings and correlations with lymph node metastasis.
Chang C; Sun X; Zhao W; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Xie W; Shen J
Radiol Med; 2020 Mar; 125(3):257-264. PubMed ID: 31823295
[TBL] [Abstract][Full Text] [Related]
9. Preoperative levels of folate receptor-positive circulating tumor cells in different subtypes of early-stage lung adenocarcinoma: Predictive value for determining extent of surgical resection.
Zhou C; Zhao R; Zhao R; Wang A; Li W
Front Oncol; 2023; 13():1119807. PubMed ID: 37139152
[TBL] [Abstract][Full Text] [Related]
10. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
[TBL] [Abstract][Full Text] [Related]
11. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
[TBL] [Abstract][Full Text] [Related]
12. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
13. The prognostic utility of the histologic subtype of stage I lung adenocarcinoma may be diminished when using only the invasive component to determine tumor size for tumor node metastasis (TNM) staging.
Sung YE; Lee KY; Moon Y
J Thorac Dis; 2021 May; 13(5):2910-2922. PubMed ID: 34164182
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
[TBL] [Abstract][Full Text] [Related]
15. Skip N2 Metastasis in Pulmonary Adenocarcinoma: Good Prognosis Similar to N1 Disease.
Wang L; Ye G; Xue L; Zhan C; Gu J; Xi J; Lin Z; Jiang W; Ge D; Wang Q
Clin Lung Cancer; 2020 Sep; 21(5):e423-e434. PubMed ID: 32245623
[TBL] [Abstract][Full Text] [Related]
16. Novel approach for predicting occult lymph node metastasis in peripheral clinical stage I lung adenocarcinoma.
Song CY; Kimura D; Sakai T; Tsushima T; Fukuda I
J Thorac Dis; 2019 Apr; 11(4):1410-1420. PubMed ID: 31179083
[TBL] [Abstract][Full Text] [Related]
17. Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.
Park S; Lee SM; Kim S; Lee JG; Choi S; Do KH; Seo JB
Radiology; 2020 Jun; 295(3):703-712. PubMed ID: 32228296
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with nodal metastasis in 2-centimeter or less non-small cell lung cancer.
Pani E; Kennedy G; Zheng X; Ukert B; Jarrar D; Gaughan C; Pechet T; Kucharczuk J; Singhal S
J Thorac Cardiovasc Surg; 2020 Mar; 159(3):1088-1096.e1. PubMed ID: 31610968
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
